CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ
Market Cap
$9.36M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
—
Rank in Industry
—
Largest Insider Buys in Sector
CERO Stock Price History Chart
CERO Stock Performance
About CERo Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Insider Activity of CERo Therapeutics Holdings, Inc.
Over the last 12 months, insiders at CERo Therapeutics Holdings, Inc. have bought $0 and sold $0 worth of CERo Therapeutics Holdings, Inc. stock.
On average, over the past 5 years, insiders at CERo Therapeutics Holdings, Inc. have bought $0 and sold $380,538 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
List of Insider Buy and Sell Transactions, CERo Therapeutics Holdings, Inc.
| 2024-10-10 | Sale | 10 percent owner | 3.25M 1.1203% | $0.10 | $325,000 | +3.54% | ||
| 2024-09-25 | Sale | 10 percent owner | 532,486 0.1914% | $0.10 | $55,538 | -5.50% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.